Preclinical Pathfinder Joins Academic Research Consortium

July 8th 2016

Preclinical Pathfinder and Duke Preclinical Translational Research Unit teamed with the NJ Institution of Innovation and other pharmaceutical industry and academic institutions to establish The Innovative Medicines Manufacturing Institute (IMMI). Our goal is to obtain a 70 million dollar grant to assist bio-pharmaceutical companies, regulatory agencies, and technology suppliers in addressing the need for next-generation manufacturing solutions.